Share Your Research, Maximize Your Social Impacts
Main Menu
Searching By
PARTNERS
2020 - Drug Manufacturing Inspection Part III
Date2020-06-03
Deadline2020-05-24
VenueOnline Event, USA - United States 
KeywordsFDA Surveillance Inspections; FDA For Cause Inspection; Compliance Program 7356.002
Topics/Call fo Papers
Background
Objectives and Strategy Related to the Compliance Program 7356.002
Strategy Related to the Compliance Program 7356.002
Scheme of Systems for the Manufacture of Drugs/Drug Products
Program Management
Investigational Operations
Analytical
Typical Deficiencies Found as a Result of Systems Inspected
Objectives and Strategy Related to the Compliance Program 7356.002
Strategy Related to the Compliance Program 7356.002
Scheme of Systems for the Manufacture of Drugs/Drug Products
Program Management
Investigational Operations
Analytical
Typical Deficiencies Found as a Result of Systems Inspected
Other CFPs
- Developing and Implementing an Effective Regulatory Tracking Process
- MHRA Guidance during the COVID-19 Emergency: Drug Regulation
- Beyond Handbooks, Benefits, and Photo IDs: The Role of HR and Management in New Employee Onboarding
- FDA Regulations for Commercializing OTC Drug Products
- Applying Six Sigma Downtime to Analytical and Bioanalytical Labs
Last modified: 2020-05-08 23:14:33